
Bob Freeman
Training and career
- Current position Consultant urogynecologist, University Hospitals Plymouth NHS Trust; part-time work in urogynecology and clinical research123
- Former position St George’s and Queen Charlotte’s/Chelsea Hospital for Women, London4
- Medical school Medicine, Dundee University (qualified 1977)4
- Leadership Past president, International Urogynecological Association34
- Leadership Past chairman, British Society of Urogynaecology34
Known for
- LAS trial of laparoscopic versus open sacrocolpopexy (2013). Freeman led a randomized equivalence trial comparing laparoscopic and open sacrocolpopexy for posthysterectomy vaginal vault prolapse.5
- PROSPECT trials of mesh, graft, and native-tissue prolapse repair (2017). Freeman was a Plymouth principal investigator in the multicenter PROSPECT trials comparing augmentation with standard vaginal prolapse repair.6 Cited on WARWIKI: Mesh & Graft-Augmented Prolapse Repair.
Cited on WARWIKI
3 publications with Bob Freeman as a listed author are cited on WARWIKI, ordered by the number of pages that cite them. Papers whose author list is shortened to "et al." before this name are not included.
- Haylen BT, de Ridder D, Freeman RM, et al. "An International Urogynecological Association (IUGA) / International Continence Society (ICS) Joint Report on the Terminology for Female Pelvic Floor Dysfunction." Neurourol Urodyn. 2010;29(1):4-20. doi
- Reid FM, Elders A, Breeman S, Freeman RM. How common are complications following polypropylene mesh, biological xenograft and native tissue surgery for pelvic organ prolapse? A secondary analysis from the PROSPECT trial. BJOG. 2021;128(13):2180–2189. doi
- Haylen BT, de Ridder D, Freeman RM, et al. An IUGA/ICS joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29:4–20. doi